Header Logo

Connection

TODD ROSENGART to Serine Proteinase Inhibitors

Back to Details
This is a "connection" page, showing publications TODD ROSENGART has written about Serine Proteinase Inhibitors.
TODD ROSENGART
Connection Strength
0.028
Serine Proteinase Inhibitors
  1. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation. 1995 Oct 15; 92(8):2236-44.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.